A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)

TerminatedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Bladder CancerCIS
Trial Locations (11)

11714

Long Island Urological Associates, Bethpage

19004

Urologic Consultants of SE PA, Bala-Cynwyd

32960

Advanced Urology Association of Florida, Vero Beach

33149

Urology Research Network, Hialeah

37232

Vanderbilt University Medical Center, Nashville

66211

Kansas City Urology Care, Overland Park

75231

Urology Clinics of North Texas, Dallas

76017

Urology Associates of North Texas, Arlington

85032

BCG Oncology, Phoenix

08080

Delaware Valley Urology, Sewell

08043

Delaware Valley Urology, Voorhees Township

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY